The Clorox Company (CLX)
Sous-évaluéFondamental
53
Prix
$80.03
Capitalisation boursière
$9.89B
Partie 1 · Ce que vaut l'entreprise
Vue d'ensemble
Clorox makes household staples sold under well-known names: bleach and cleaning sprays under its own Clorox brand, trash bags under Glad, charcoal under Kingsford, and personal-care and health products including Burt's Bees. It manufactures most of what it sells, ships it to large retailers, and relies on repeat, habitual purchases rather than one-off sales — a household restocks bleach or trash bags on a predictable cycle regardless of the wider economy.
Comment l'entreprise gagne de l'argent
Revenue comes from selling packaged goods to a concentrated set of large retailers, who then resell to shoppers. Margins depend on the cost of raw materials such as resin and chemicals, on manufacturing efficiency, and on holding shelf space and brand loyalty against cheaper private-label alternatives that retailers sell alongside Clorox's own products. The company reports results across four segments split by product category and by U.S. versus international markets.
Chiffre d'affaires par segment
Cleaning and disinfecting products under Clorox, plus water filtration under Brita and vitamins under Natural Vitality.
Trash bags under Glad, cat litter under Fresh Step and Scoop Away, and charcoal under Kingsford.
Food products including Hidden Valley dressings, and personal care through Burt's Bees.
The same core product categories sold outside the United States, mainly in Latin America and Canada.
Avantage concurrentiel
Marque · ÉtroitNames like Clorox, Glad and Kingsford have been the default choice on U.S. shelves for generations, which lets the company hold shelf space and charge more than an unbranded equivalent. The advantage is narrow: retailer store brands compete directly in nearly every category, and a large retailer with real pricing leverage can push back hard on Clorox's terms.
Ce qui stimule la demande
DéfensifCleaning products, trash bags and personal care items are routine, non-discretionary household purchases that people keep buying in a downturn, which makes volume relatively stable across the economic cycle. The bigger swings in results tend to come from input-cost inflation and from consumers trading down to private label when money is tight, not from skipping the purchase altogether.
Principaux risques
- Retailer concentration — With Walmart alone worth nearly 27% of net sales, large retailers have the leverage to demand better pricing terms or to favour their own private-label products over Clorox's brands.
- Input cost and supply chain disruption — Volatile commodity, packaging, labour, energy and logistics costs, along with the risk of supply disruption from conflicts such as those in Ukraine, the Middle East, or tensions between China and Taiwan, can raise costs faster than prices can be adjusted.
- Cybersecurity — The company depends heavily on information technology systems and has already suffered a major cyberattack, in August 2023, that disrupted operations; a repeat incident could again halt production and shipments.
- Private-label competition — Store-brand alternatives, often priced well below Clorox's products, compete in nearly every category the company sells in, forcing continued spending on marketing and innovation to defend market share.
Concentration des clients
Les principaux clients représentent 27% du chiffre d'affaires
Walmart and its affiliates accounted for nearly 27% of net sales in fiscal 2025, giving a single retailer significant leverage over shelf placement, promotional terms and pricing.
Les arguments en faveur
Buyers argue that Clorox's brands are habit-forming staples that hold shelf space no private label can fully dislodge, and that the company's cost-savings programme and full recovery from the 2023 cyberattack position it to grow margins even on roughly flat sales.
Les arguments contre
Sellers worry that with Walmart alone worth over a quarter of sales, Clorox has limited room to push back on retailer demands, and that persistent private-label competition plus input-cost inflation could keep squeezing volumes and margins at the same time.
Written by the editors, published on 18 août 2026
Direct competitors
Who this company fights with for the same customers
Generated on 18 septembre 2026 with claude-haiku-4-5 — shared with all users
Reckitt's Lysol is the closest rival to Clorox's core disinfecting bleach, sprays and wipes, fighting for the same shelf space and the same household and professional cleaning budgets in North America.
Church & Dwight sells Arm & Hammer cleaning and laundry additives, cat litter and personal care to the same value-minded U.S. grocery and mass-market shopper Clorox depends on.
P&G's Mr. Clean, Swiffer, Dawn and Febreze compete directly with Clorox's home-cleaning lines for the same retail shelf and promotional slots, backed by far larger advertising and R&D budgets.
Colgate-Palmolive's home-care brands — Fabuloso, Ajax, Murphy Oil Soap — target the same surface-cleaning customer in the United States and in Clorox's Latin American markets.
This privately held U.S. group competes across several Clorox aisles at once: Windex and Scrubbing Bubbles against Clorox cleaners, Ziploc against Glad bags and wraps, Glade against home fragrance.
Unilever competes with Clorox on two fronts: Domestos and Cif bleach and surface cleaners outside the U.S., and Dove, Vaseline and Simple against Burt's Bees in natural personal care.
Bilan & Liquidités
Chiffre d'affaires
$6.76B
12 derniers mois (au 31/03/2026)
Résultat net
$756M
12 derniers mois (au 31/03/2026)
Flux de trésorerie libre
$761M
Capitaux propres totaux
$321M
Passif total
$5.08B
Ratio de liquidité général
0.84
Couverture des intérêts
-
Dette/EBITDA
3.94
Bénéfice par action
Chiffre d'affaires & Résultat net
Flux de trésorerie libre
Décomposition du résultat
État historique
Marges dans le temps
La dette dans le temps
Le poids de la dette
Grille de la croissance
Croissance — Chiffre d'affaires
Estimation de la juste valeur
Juste valeur
$108.06
Prix actuel
$80.03
Marge de sécurité
+25.9%
Fourchette de juste valeur
$70.24 - $145.88
Écart entre les méthodes de valorisation utilisées, pas un intervalle de confiance calibré statistiquement.
Méthodes d'estimation
Indicateurs de valorisation
Ratio P/E
13.15
ROE
252.3%
Ratio P/B
30.81
P/FCF
25.78
Marge brute
43.8%
ROIC
-
Radar de rentabilité
Création de valeur (avantage concurrentiel)
ROIC
-
WACC
6.0%
ROIC − WACC
-
Critères d'analyse fondamentale
Réussi (12)
- EPS shows upward trend
- Gross Margin 43.8%
- P/FCF 25.78
- Positive Free Cash Flow
- Current Ratio
- Debt/EBITDA
- Return on Tangible Assets
- ROE 181.1%
- Earnings Quality (OCF/NI) 0.76
- Share Dilution -0.2%
- Net Margin Trend 11.2% vs 9.9%
- Piotroski F-Score 8/9
Échoué (11)
- EPS CAGR 4.22%
- Price CAGR -3.51%
- P/B Ratio 30.81
- Debt/Equity ratio
- CapEx intensity
- Low reliance on intangibles
- Price below Graham Number
- DCF valuation (Fairly valued)
- Revenue Growth 5Y -1.8%
- Analyst Consensus 4% Buy
- Earnings Surprise avg 1.8%
Indisponible (5)
- ROIC NaN%
- Dividend Payout NaN%
- Operating Margin NaN%
- Interest Coverage
- PEG Ratio (need PE > 0 and growth > 0)
Score F de Piotroski
Santé financière solide
Qualité des bénéfices
Modérée : certain écart entre profits et trésorerie
Dilution du capital
Rachat d'actions. Favorable aux actionnaires
Participations institutionnelles
Gouvernance
Équipe dirigeante
| Nom | Titre | Âge |
|---|---|---|
| Ms. Linda J. Rendle | CEO & Chairman | 47 |
| Mr. Luc Bellet | Executive VP & CFO | 46 |
| Mr. Chris T. Hyder | Executive VP & COO | 50 |
| Ms. Nina Barton | Executive VP and Chief Growth & Strategy Officer | 51 |
| Ms. Laura E. Peck | VP, Chief Accounting Officer & Corporate Controller | 48 |
| Ms. Chau Banks | Senior VP and Chief Information & Data Officer | 56 |
| Ms. Kirsten M. Marriner | Executive VP & Chief Administrative Officer | 52 |
| Ms. Lisah Burhan | Vice President of Investor Relations | - |
| Ms. Angela C. Hilt | Executive VP, Chief Legal & External Affairs Officer and Corporate Secretary | 53 |
| Mr. Eric Sean Schwartz | Senior VP & Chief Marketing Officer | 53 |
Risque d'audit
7
Risque du conseil
3
Risque de rémunération
6
Risque droits des actionnaires
8
Partie 2 · Le prix et le moment d'entrer
Cette partie ne dit pas si l'entreprise vaut la peine : elle aide à choisir quand l'acheter, une fois que les fondamentaux vous ont convaincu. À l'intérieur : analyse technique, potentiel, baisses historiques, exposition gamma.
Documents
- Voir le document
Rapport annuel (10-K)
Un aperçu annuel de l'activité, des résultats financiers et des risques de l'entreprise.
Déposé le 2026-08-07
- Voir le document
Rapport trimestriel (10-Q)
Une mise à jour de la performance financière des trois derniers mois.
Déposé le 2026-04-30
- Voir le document
Rapport d'événement important (8-K)
Un avis concernant un événement important, comme un changement de direction ou une annonce majeure.
Déposé le 2026-08-03
via SEC EDGAR
Historique des résultats
via SEC EDGAR
Latest News
Recent headlines for CLX, sourced from Markets Gazette.
- 8/3/2026POSITIVEClorox Expects Full-Year Sales Boost From Purell Deal
The Clorox Company announced fiscal fourth-quarter earnings that surpassed analyst forecasts, signaling resilience despite challenges. While sales volumes were down and the recent acquisition of GOJO Industries, the maker of Purell, incurred additional logistics costs, the overall financial performance indicates effective management. The company anticipates a full-year sales boost stemming from the Purell integration, suggesting a positive outlook for future revenue streams. Investors will be watching the successful integration of GOJO and its impact on Clorox's market position and profitability in the coming quarters.
via Markets Gazette